Skip to content
  • Sunday, 26 July 2026
  • 3:13 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Genes offer new clues to stopping Huntington’s disease in its tracks
Environmental & Analytical Chemistry

Genes offer new clues to stopping Huntington’s disease in its tracks

Abdurrohim Arsyad Jul 17, 2026 0

The origins of Science News can be traced back to a period of burgeoning scientific advancement and a growing public…

Read More
Pharmaceutical R&D

UniQure Secures Path to Regulatory Review for Groundbreaking Huntington’s Disease Gene Therapy After FDA Reversal

Teuku Ryan Jun 18, 2026 0

UniQure has announced a significant turning point in its pursuit of regulatory approval for AMT-130, a pioneering gene therapy aimed…

Read More
Biotech & Genetic Research

Groundbreaking Research Uncovers How Cellular Tunnels Drive Huntington’s Disease Progression, Revealing Novel Therapeutic Avenue

Jia Lissa May 8, 2026 0

A recent scientific breakthrough, spearheaded by a team of researchers from Florida Atlantic University (FAU), has fundamentally reshaped our understanding…

Read More
Pharmaceutical R&D

Expert Insights Emerge on First Successful Huntington’s Disease Gene Therapy Trial Amidst FDA Challenges

Teuku Ryan Mar 20, 2026 0

Despite promising clinical outcomes from the first-ever gene therapy trial for Huntington’s Disease (HD), a leading expert involved in the…

Read More
From Chaos to Clarity New Research Reveals How the Hippocampus Prunes Its Way to Memory EfficiencyMastering Advanced Python Techniques: Essential Concepts for High-Performance Data ScienceCornell University Researchers Develop Breakthrough Reversible Nonhormonal Male Contraceptive Method Targeting MeiosisBreast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ